Home › Mantle Cell Lymphoma
Pag-aaral pangklinika para sa Mantle Cell Lymphoma na nagre-recruit sa U.S.
73 pag-aaral para sa Mantle Cell Lymphoma ang nagre-recruit ng mga kalahok sa mga site sa buong Estados Unidos.
Mga lungsod na may pinakamaraming pag-aaral
- Baldwin Park, CA17 pag-aaral
- Houston, TX15 pag-aaral
- Durham, NC13 pag-aaral
- Seattle, WA13 pag-aaral
- Milwaukee, WI12 pag-aaral
- New York City, NY12 pag-aaral
- Boston, MA11 pag-aaral
- Columbus, OH11 pag-aaral
- Nashville, TN11 pag-aaral
- Chicago, IL10 pag-aaral
- Portland, OR9 pag-aaral
- Rochester, MN9 pag-aaral
- Denver, CO8 pag-aaral
- St. Louis, MO8 pag-aaral
- Atlanta, GA8 pag-aaral
- Salt Lake City, UT7 pag-aaral
- Cleveland, OH7 pag-aaral
- Los Angeles, CA7 pag-aaral
- Ann Arbor, MI7 pag-aaral
- Mountain View, CA7 pag-aaral
- Dallas, TX6 pag-aaral
- Miami, FL6 pag-aaral
- Jacksonville, FL6 pag-aaral
- New Haven, CT5 pag-aaral
- Baltimore, MD5 pag-aaral
- Edison, NJ5 pag-aaral
- Philadelphia, PA5 pag-aaral
- Washington, DC5 pag-aaral
- San Diego, CA5 pag-aaral
- Kansas City, MO5 pag-aaral
- Tampa, FL5 pag-aaral
- Buffalo, NY5 pag-aaral
- Queens, NY4 pag-aaral
- Charlotte, NC4 pag-aaral
- Richmond, VA4 pag-aaral
- Birmingham, AL4 pag-aaral
- Winston-Salem, NC4 pag-aaral
- Charlottesville, VA4 pag-aaral
- Omaha, NE4 pag-aaral
- Cedar Rapids, IA4 pag-aaral
Ayos sa estado
- Alabama4 pag-aaral
- Arizona6 pag-aaral
- California31 pag-aaral
- Colorado10 pag-aaral
- Connecticut6 pag-aaral
- Delaware3 pag-aaral
- Florida16 pag-aaral
- Georgia9 pag-aaral
- Illinois10 pag-aaral
- Indiana4 pag-aaral
- Iowa5 pag-aaral
- Kansas7 pag-aaral
- Kentucky4 pag-aaral
- Louisiana3 pag-aaral
- Maryland9 pag-aaral
- Massachusetts13 pag-aaral
- Michigan9 pag-aaral
- Minnesota14 pag-aaral
- Missouri8 pag-aaral
- Nebraska4 pag-aaral
- New Jersey8 pag-aaral
- New York16 pag-aaral
- North Carolina16 pag-aaral
- Ohio16 pag-aaral
- Oregon9 pag-aaral
- Pennsylvania9 pag-aaral
- Rhode Island4 pag-aaral
- Tennessee12 pag-aaral
- Texas19 pag-aaral
- Utah7 pag-aaral
- Virginia7 pag-aaral
- Washington15 pag-aaral
- Wisconsin13 pag-aaral
Mga pag-aaral na kamakailan lamang in-update
Opisyal na teksto ng pag-aaral (English)
Testing the Anti-cancer Drug, Glofitamab, in Patients With Mantle Cell Lymphoma (A Type of Blood Cancer) Whose Disease Returned After CAR-T Cell Therapy
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT07003295Phase II Study of Pirtobrutinib, Rituximab (PR) in Previously Untreated Low and Intermediate Risk MCL (Mantle Cell Lymphoma) Patients
Nagre-recruitPhase 2Malugod na tinatanggap ang malusog na boluntaryo
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 10, 2026 · NCT06263491BAFFR-targeting CAR T Cells for Patients With Relapsed or Refractory B-NHL
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 10, 2026 · NCT05370430A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT07101328Auto Stem Cell Transplant for Lymphoma Patients
Nagre-recruitPhase 2
Hanggang edad 75 · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT03125642Testing Continuous Versus Intermittent Treatment With the Study Drug Zanubrutinib for Older Patients With Previously Untreated Mantle Cell Lymphoma
Nagre-recruitPhase 3
Edad 60 pataas · Lahat ng kasarian · Na-update Nob 3, 2026 · NCT05976763Acalabrutinib, Obinutuzumab, and Glofitamab for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 3, 2026 · NCT06054776A Study of ARC-02 in B-cell NHL
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 2, 2026 · NCT07691606Sonrotoclax, Rituximab, and Zanubrutinib in Treating Participants With Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, and Mantle Cell Lymphoma
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 30, 2026 · NCT06839053A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL)
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 29, 2026 · NCT06742996Observational Study of Cardiac Arrhythmias During Treatment With BTK Inhibitors or Venetoclax
Nagre-recruitObservasyonal na pag-aaral
Edad 18 hanggang 110 · Lahat ng kasarian · Na-update Okt 29, 2026 · NCT05724121A Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell Malignancies
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 28, 2026 · NCT06564038Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
Nagre-recruitObservasyonal na pag-aaral
Edad 18 hanggang 120 · Lahat ng kasarian · Na-update Okt 28, 2026 · NCT01137643Glofitamab With Obinutuzumab, Venetoclax, and Lenalidomide for the Treatment of Patients With Newly Diagnosed High Risk Mantle Cell Lymphoma
Nagre-recruitPhase 1/2
Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Okt 26, 2026 · NCT05861050A Study to Investigate the Safety of Novel Dose Ramp-up Schedule(s) When Initiating Sonrotoclax in Participants Treated for Blood Cancers.
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 26, 2026 · NCT06697184Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
Nagre-recruitPhase 1/2
Edad 13 hanggang 90 · Lahat ng kasarian · Na-update Okt 26, 2026 · NCT06533579Anti-CD19 Chimeric Antigen Receptor T Cells for Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 26, 2026 · NCT04545762Natalizumab for the Prevention of ICANS in Patients With Recurrent or Refractory Diffuse Large B-Cell Lymphoma or Mantle Cell Lymphoma Receiving CAR T-Cell Therapy
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 23, 2026 · NCT07892027Golcadomide in Combination With Rituximab for the Treatment of Patients With Relapsed or Refractory Mantle Cell Lymphoma
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 22, 2026 · NCT07578077A Study of APG-3288 in Relapsed/Refractory Blood Cancers
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 15, 2026 · NCT07424833Pacritinib in Combination With a BTK Inhibitor for the Treatment of Patients With Relapsed or Refractory Mantle Cell Lymphoma
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 14, 2026 · NCT06675123Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 14, 2026 · NCT03523975CD79b-19 CAR T Cells in Non-Hodgkin Lymphoma
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 9, 2026 · NCT06026319A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT05006716Intrathecal Cytarabine and Hydrocortisone for the Early Treatment of ICANS in Patients Undergoing CAR T Therapy for Non Hodgkin Lymphoma
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT07763210Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.